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Summary
A Plasmodium falciparum hexose transporter (PfHT)
has previously been shown to be a facilitative glucose
and fructose transporter. Its expression in Xenopus
laevis oocytes and the use of a glucose analogue
inhibitor permitted chemical validation of PfHT as a
novel drug target. Following recent re-annotations of
the P. falciparum genome, other putative sugar trans-
porters have been identiﬁed. To investigate further if
PfHT is the key supplier of hexose to P. falciparum
and to extend studies to different stages of Plasmo-
dium spp., we functionally analysed the hexose trans-
porters of both the human parasite P. falciparum and
the rodent parasite Plasmodium berghei using gene
targeting strategies. We show here the essential func-
tion of pfht for the erythrocytic parasite growth as it
was not possible to knockout pfht unless the gene
was complemented by an episomal construct. Also,
we show that parasites are rescued from the toxic
effect of a glucose analogue inhibitor when pfht is
overexpressed in these transfectants. We found that
the rodent malaria parasite orthologue, P. berghei
hexose transporter (PbHT) gene, was similarly refrac-
tory to knockout attempts. However, using a single
cross-over transfection strategy, we generated trans-
genic P. berghei parasites expressing a PbHT–GFP
fusion protein suggesting that locus is amenable for
gene targeting. Analysis of pbht-gfp transgenic para-
sites showed that PbHT is constitutively expressed
through all the stages in the mosquito host in addition
to asexual stages. These results provide genetic
support for prioritizing PfHT as a target for novel
antimalarials that can inhibit glucose uptake and kill
parasites, as well as unveiling the expression of this
hexose transporter in mosquito stages of the para-
site, where it is also likely to be critical for survival.
Introduction
Malaria still afflicts around 500 million people and contin-
ues to kill around 1 million children a year. The recent
emergenceofresistancetoartemisinin(Noedlet al.,2008;
Dondorp et al., 2009), the last line of defence against
multi-resistant parasites in some parts of the world, makes
the search for new antimalarial drug targets an urgent one.
Although transport proteins are excellent drug targets in
other systems (Imming et al., 2006), they are underex-
ploited as targets in Plasmodium falciparum, the most
pathogenic malarial parasite, and other Plasmodium spp.
(Cowman and Crabb, 2003).
We ﬁrst identiﬁed the hexose transporter of P. falci-
parum (PfHT, PFB0210c) as a potential drug target by
studying its function after expression in Xenopus laevis
oocytes, and demonstrating selective inhibition of PfHT
versus mammalian orthologues using an o-3 undecenyl
glucose derivative (CM3361) (Joet et al., 2003). These
studies were extended to the Plasmodium berghei murine
model, to establish that CM3361 can attenuate parasi-
taemias in vivo. There is also added value (in addition to
parasite clearance) in inhibiting glucose uptake by
infected erythrocytes, because competition for this sub-
strate between the parasite and the host tissue may be
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© 2010 Blackwell Publishing Ltdeliminated rapidly. Interfering with metabolic diversion of
glucose may be particularly important in cerebral tissues
in syndromes like cerebral malaria, where glucose deliv-
ery may become rate limiting.
PfHT is a facilitative hexose transporter in the Major
Facilitator Superfamily of integral membrane proteins that
mediates the uptake of glucose and fructose by the para-
site (Woodrow et al., 1999). Pfht is a single copy gene in
the P. falciparum genome with no close paralogues. Three
other proteins, PFI0955w, PFI0785c and PFE1455w have
been annotated with putative sugar transport function
(Gardner et al., 2002; Martin et al., 2005), although they
have diverged considerably from typical sugar transport-
ers (21%, 13% and 7% amino acid sequence identity
compared with PfHT, respectively). Unlike PfHT,
PFI0955w and PFI0785c are expressed only late in the
asexual cycle. Together with chemical validation data
demonstrating that PfHT is essential for parasite survival,
this makes it unlikely that PFI0955w and PFI0785c func-
tion in alternative mechanisms for delivery of hexoses as
energy substrates for P. falciparum. To test this hypoth-
esis, we performed gene transfection experiments aiming
at determining the essentiality (or otherwise) of pfht in P.
falciparum and of its orthologue in P. berghei (pbht,
PB000562.01.0). We also generated Pbht-gfp transgenic
parasites and employed them in the visualization of
expression of this transporter during malaria parasite
development. In addition, we also attempted to correlate
the level of pfht expression in a transfected P. falciparum
line with susceptibility to a speciﬁc inhibitor, CM3361.
Results
Pfht is indispensable for the erythrocytic development in
P. falciparum
To test if pfht can be disrupted during the asexual stages
of P. falciparum, two transfection experiments were per-
formed (Fig. 1A). In the ﬁrst transfection, 3D7 parasites
Fig. 1. A. Strategy for disruption of the PfHT
gene. Single cross-over homologous
recombination of the knockout plasmid and
the endogenous gene results with two
truncated copies of the gene. The location of
PCR primers is indicated by numbered
arrows. Restriction sites of enzymes used to
digest genomic DNA prior to Southern blotting
and expected Southern blot fragments are
also indicated. The complementation
construct (pCHD-HT) allows pfht expression
under the Pfhsp86 promoter.
B. Plasmid rescue of episomes from
transfected parasites. Lane 1: re-isolated
episome from parasites transfected with the
knockout construct (pCAM-BSD-HT). Lanes 2
and 4: re-isolated episomes from parasites
co-transfected with the knockout and the
complementation construct (pCHD-HT). Lane
3: pCAM-BSD-HT plasmid. Lane 5: pCHD-HT
plasmid. BamHI-NotI digestion releases
a 1.2 kb knockout fragment from
pCAM-BSD-HT. BglII-NotI digestion releases
the PfHT gene (1.5 kb) and an additional
1.2 kb fragment from pCHD-HT.
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BSD-HT. Transfected populations were subjected to blas-
ticidin pressure, and blasticidin-resistant parasites were
readily obtained (14 days post transfection). The second
transfection consisted of electroporation of 3D7 parasites
with both the knockout and the complementation
constructs. Double selection with blasticidin and
WR99210 was applied 48 h post transfection. Doubly
resistant parasites appeared in the culture somewhat later
than blasticidin-resistant parasites, 19 days after the
electroporation.
Episomal plasmids were recovered from all transfected
parasites by plasmid rescue to conﬁrm that parasites con-
tained the right constructs (Fig. 1B). Bacterial clones
transformed with genomic DNA from blasticidin-resistant
parasites all contained pCAM-BSD-HT plasmid while bac-
terial clones transformed with genomic DNA from doubly
resistant parasites carried either the pCAM-BSD-HT or
the pCHD-HT plasmid.
Genomic DNAwas isolated from both singly and doubly
transfected parasites at various stages and was analysed
by PCR to establish if integration of the knockout vector
and disruption of pfht had occurred.
Wefoundwewerenotabletoobtainaknockoutofpfhtin
parasites transfected only with the knockout vector. PCR
detectedonlythewild-typelocusandepisomalpresenceof
the knockout construct, but did not show any amplicons
diagnosticforintegrationoftheconstructintothepfhtlocus
(Fig. 2A). This suggests that the pfht gene is essential for
survival of asexual stages ofP. falciparum. Co-transfection
of 3D7 parasites with both the knockout and the comple-
mentation constructs conﬁrms that pfht locus is accessible
for homologous recombination. PCR analysis of these
parasites detected bands corresponding to the 5′ and 3′
ends of the pCAM-BSD-HT integration event (Fig. 2A). A
wild-type locus was still detectable in these parasites,
indicative of a genotypically diverse population of para-
sites. To select for parasites with a disrupted pfht locus,
blasticidin selective pressure was removed for 3 weeks.
During this time, parasites would tend to lose the pCAM-
BSD-HT episome.After 3 weeks, blasticidin was reapplied
for another 3 weeks and in this time parasites with pCAM-
BSD-HT integrated into their genome would be positively
selected (as the PfHT protein was expressed from the
complementing plasmid also present in the cells). This
cycling selection was repeated twice. PCR analysis on
genomic DNA isolated from parasites selected in this way
(below referred to as complemented) showed complete
lossofthepfhtwild-typelocus,andpresenceofthepCAM-
BSD-HT integration and episome (Fig. 2A).
Southern blot analysis was performed to conﬁrm geno-
types (Fig. 2B). When probed with a pfht fragment, DNA
from blasticidin-resistant single-transfected parasites
yielded two bands corresponding to the wild-type locus
and the knockout plasmid (3 kb and 5.7 kb, respectively),
while doubly resistant parasites contained pCAM-
BSD-HT integrated into the pfht locus (4.7 kb and 3.9 kb)
and complete loss of the wild-type locus after cycling with
blasticidin pressure.Additionally, complemented parasites
showed more complicated Southern blot patterns, sug-
gesting that super-integration events of both plasmids
may have occurred in these parasites, as previously
observed in similar instances of complementation
approaches (Dorin-semblat et al., 2007).
Fig. 2. Genotype analysis of wild-type 3D7 parasites and parasites transfected with pCAM-BSD-HT alone or co-transfected with
pCAM-BSD-HT and pCHD-HT.
A. PCR analysis: lane 1, detection of the wild-type pfht locus 2 kb (primers 1 + 2, see Fig. 1); lane 2, detection of the 5′ integration of
pCAM-BSD-HT into the pfht locus ~1.8 kb (primers 1 + 4); lane 3, detection of the 3′ integration of pCAM-BSD-HT ~1.7 kb (primers 3 + 2);
lane 4, detection of the pCAM-BSD-HT episome 1.4 kb (primers 3 + 4).
B. Southern blot analysis. Genomic DNA extracted from wild-type 3D7 parasites (lane 1), parasites transfected with pCAM-BSD-HT (lane 2),
selected parasites co-transfected with pCAM-BSD-HT and pCHD-HT after blasticidin cycling – complemented parasites (lane 3) and
unselected co-transfected parasites prior to blasticidin cycling (lane 4), and plasmid DNA, pCAM-BSD-HT (lane 5) and pCHD-HT (lane 6) were
digested with SwaI, NcoI and EcoNI. The blot was probed with the 1.2 kb pfht fragment that was used as an insert for the pCAM-BSD-HT
plasmid; wild-type locus 3 kb, integration of pCAM-BSD-HT 4.7 kb (5′) and 3.9 kb (3′), pCAM-BSD-HT episome 5.7 kb, pCHD-HT episome
8.3 kb.
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overexpression of pfht
Our complemented transgenic P. falciparum parasites do
not express PfHT from the endogenous locus (which is
disrupted in these parasites, see Fig. 2), but from the
complementing episome, which drives the expression of
PfHT from the Pfhsp86 promoter. Complemented para-
sites have shown a stable phenotype as their removal
from the WR99210 selective pressure for a prolonged
period did not result in an impaired growth upon the
restoration of the selection when compared with com-
plemented parasites continuously cultured exposed to
WR99210 (not shown). This ﬁnding suggests that para-
sites were not losing the complementation plasmid in the
absence of the selection drug.
Because the Pfhsp86 promoter is highly active through-
out the asexual cycle, it can be predicted that PfHT levels
are higher in the transgenic parasites than in wild-type
cells.Totestthishypothesis,wemeasuredthesensitivityof
both lines to CM3361, a speciﬁc inhibitor of PfHT. When
compared with wild-type 3D7, complemented parasites
with episomal pfht expression showed a 2.5-fold increase
in IC50 value for CM3361 (44.2  8.7 and 109.5  9.6 mM,
respectively; P = 0.001 student’s t-test, unpaired, two-
tailed, n = 5) (Fig. 3A). The sensitivity to chloroquine was
the same for these two strains of parasites (wild type:
17.6  4.8 nM, n = 4; complemented transfectants:
15.3  2.6 nM, n = 3; P = 0.7 student’s t-test, unpaired,
two-tailed). The possibility exists that the 2.5-fold shift in
the parasite sensitivity to 3361 is due to an off-target effect
as a result of selection with blasticidin and WR99210
although this is less likely given the parasite’s unaffected
sensitivity to chloroquine, an unrelated compound.
Using quantitative PCR technology, pfht expression
was compared at ring (~10 h post invasion) and tropho-
zoite stages (~30 h post invasion) in transfected and
control cell lines. Signiﬁcantly increased pfht expression
at the trophozoite stage (approximately threefold) was
found in complemented parasites compared with 3D7
parasites. In ring-stage parasites there was no difference
between the experimental groups (Fig. 3B).
PbHT is essential for erythrocytic stages of P. berghei
Taking into account reported differences between P. falci-
parum and P. berghei, we were interested to investigate if
the P. berghei hexose transporter (PbHT) is also essential
for parasite growth similarly to its P. falciparum orthologue.
Pbht 5′ and 3′ untranslated regions were cloned upstream
and downstream of the dihydrofolate reductase (DHFR)
cassette, respectively, in the knockout construct designed
for double cross-over homologous recombination. Under
pyrimethamine drug pressure, parasites containing the
DHFR cassette were selected after three independent
transfection experiments. PCR on genomic DNA obtained
from all three drug-resistant populations did not detect any
integration of the knockout construct or disruption of pbht,
suggesting the essential function of the gene (Fig. 4). In
contrast, we readily obtained transfected P. berghei para-
sites containing the integration of the PbHT-GFPconstruct
into the pbht locus. This generated transgenic parasites
expressing C-terminally GFP-tagged PbHT, which demon-
stratesthatthelocusisaccessibleforgenetictargetingand
conﬁrmstheessentialityofthehexosetransportergenefor
completion of the erythrocytic asexual cycle of malaria
parasites (Fig. 5).
Fig. 3. Phenotype analysis of wild-type 3D7 parasites and complemented parasites.
A. Effect of compound 3361 on growth of wild-type 3D7 parasites (squares) and complemented parasites (circles). Complemented parasites
have disrupted endogenous pfht locus, instead pfht is expressed from pCHD-HT episome under the pfhsp86 promoter. Growth inhibition was
measured by incorporation of
3H-hypoxanthine with ﬁve replicates used per inhibitor concentration. The experiment was repeated ﬁve times.
Result of a single experiment is shown. Obtained 3361 IC50 values for 3D7 and complemented parasites were 44.2  8.7 and 109.5  9.6 mM
respectively (P = 0.001 student’s t-test, unpaired, two-tailed, n = 5).
B. Real-time PCR analysis of pfht expression normalized to b-tubulin in wild-type 3D7 (white bars) and complemented parasites (black bars)
(result of 6 experiments with 3 replicates each, one sample t-test, *P = 0.015).
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Available microarray data (PlasmoDB, Version 6.2) indi-
cate that PfHT mRNA is detectable throughout the
erythrocytic stages of development. Direct ﬂuorescence
imaging of blood stages of pbht-gfp transgenic parasites
reveals ﬂuorescence signal associated with the para-
site’s plasma membrane present in both early and late
blood stages (Fig. 6A and B), demonstrating that PbHT
protein is indeed present throughout the asexual cycle.
Some of the observed ﬂuorescence signal is internal
and may be associated with perinuclear localization as
Fig. 4. Pbht knockout attempt.
A. A double cross-over knockout strategy
used to attempt a knockout of pbht and
investigate its function; the locations of
primers used for PCR analysis of the locus
are indicated by arrows. Tg DHFR/TS,
Toxoplasma gondii dihydrofolate
reductase/thymidylate synthase.
B. PCR analysis of the pbht locus in wild type
(WT) and parasites transfected with the
knockout construct; lane 1, detection of the
wild-type locus 1.1 kb (primers Pb7 + Pb9);
lane 2, integration detection 1.2 kb (primers
p539 + Pb9); lane 3, episome detection 1.1 kb
(primers p539 + Pb8).
Fig. 5. Tagging of the pbht locus with GFP.
A. The strategy for GFP-tagging of the pbht
locus; arrows indicate the location of PCR
primers.
B. PCR analysis of the wild type (WT) and a
pyrimethamine-resistant pbht-gfp transfected
line. Lane 1, positive control 2.3 kb (primers
Pb1 + Pb11); lane 2, detection of the
gfp-tagged locus 2.4 kb (Pb1 + gfpr); lane 3,
detection of the wild-type locus 3.2 kb
(Pb1 + Pb8).
C. Southern blot analysis of wild-type (1) and
pbht-gfp transfected line (2). gDNA was
digested with BsrGI, and blot was probed with
a pbht fragment used for generation of the
tagging construct; wild-type locus 3.9 kb,
integration bands 1.8 kb (5′) and 8.1 kb (3′).
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are needed to ascertain this point. Observed internal
PbHT-GFP signal could be associated with developing
PbHT in its trafficking pathway or may come from a
small proportion of PbHT-GFP protein that has been
mislocalized. It is noteworthy that taken together with all
our other work supporting the essentiality of this trans-
porter, mislocalization of a greater proportion of the
protein would have had functional consequences that
have not been observed.
Very limited information is available regarding glucose
uptake during the sexual stages of malaria parasite devel-
opment especially during its development within the
mosquito. We used the pbht-gfp transgenic parasites to
Fig. 6. Direct ﬂuorescence imaging of pbht-gfp transgenic line.
A. A young, blood-stage pbht-gfp P. berghei parasite.
B. Two pbht-gfp P. berghei trophozoites inside an erythrocyte.
C. Zygotes/or female gametes; interestingly a smaller round cell containing surface GFP ﬂuorescence but no P28 staining is also observed.
D. Analysis of ﬂuorescence intensities across the ookinete cell.
E. Ookinete [C–E: live parasites from 20 to 24 h culture in the ookinete medium, immunostained with a monoclonal antibody against the
female gamete/zygote/ookinete marker P28 (red); DAPI was used as a nuclear dye (blue)].
F. A. stephensi midgut 11 days post infection.
G. Sporulating midgut oocyst 21 days post infection.
H. Sporozoites released from ruptured midgut oocysts.
I. Sporozoites released from salivary glands of A. stephensi 21 days post infection.
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parasite’s development in the mosquito host.
We analysed PbHT-GFP expression in live parasites
from an ookinete-enriched culture, and showed its
expression and colocalization with P28, a surface marker
of the ookinete, female gamete and zygote (Fig. 6C–E).
Analysis of mosquito midgut oocysts dissected 11 days
post infection showed internal foci of ﬂuorescence of
developing sporoblasts and lower intensity membrane
ﬂuorescence signal (Fig. 6F). Twenty-one days post infec-
tion, strong ﬂuorescence signal was detectable from
sporulating oocysts and oocyst-derived sporozoites
(Fig. 6G and H). Similarly, sporozoites released from dis-
sected salivary glands 21 days post infection showed
expression of PbHT-GFP (Fig. 6I).
Expression of PbHT-GFP in parasites from all analysed
developmental stages was conﬁrmed by Western blotting
using an anti-GFP monoclonal antibody (Fig. 7). As a
positive control for blotting and antibody staining, we used
PbGFPCON line, a P. berghei line that constitutively
expresses GFP throughout the life cycle (Franke-Fayard
et al., 2004). A protein band of ~82 kDa appeared for all
analysed pbht-gfp samples, which corresponds to a pre-
dicted mass of PbHT–GFP fusion protein (84.4 kDa).
Discussion
Identifying inhibitors of the parasite’s essential nutrient
uptake pathways may lead to the development of novel
antimalarials. The P. falciparum hexose transporter,
PfHT, has previously been investigated using chemical
validation methodologies, which suggested that a func-
tional PfHT molecule is required for parasite survival
(Joet et al., 2003). The present study now provides
genetic evidence that PfHT is indeed indispensable for
erythrocytic stages of P. falciparum. Pfht could not be
disrupted in the genome unless its expression was
maintained by an exogenously supplied construct. We
have further predicted that altered pfht expression would
lead to changes in the parasite’s sensitivity to a speciﬁc
inhibitor of PfHT, 3361. We therefore investigated the
transfected line containing PfHT expressed only from a
complementing episome and lacking endogenous pfht.
Quantitative PCR showed signiﬁcantly increased expres-
sion of pfht in these parasites compared with wild-type
controls at the trophozoite stage, whereas expression at
ring stages was not affected. A previous study showed
the peak of pfht expression to be at the early ring stage
(8 h post invasion), with falling expression at the late
ring stage (16 h) and intermediate levels of expression
at the trophozoite stage (Woodrow et al., 1999). This
indicates that highly regulated pfht expression in wild-
type parasites can be replaced by higher but less regu-
lated pfht expression in transfected lines. In support of
this ﬁnding, the transfected line was also more resistant
to growth inhibition by CM3361 (2.5-fold increase in
mean IC50 values compared with controls; P < 0.001).
These ﬁndings further validate PfHT as a novel target
and provide strong evidence that PfHT is the speciﬁc
target of CM3361 in parasites.
Although there is a growing evidence for a functional
TCA cycle in blood stages of P. falciparum, its role is not
fully deﬁned. Expression proﬁling studies of P. falciparum
parasites from patients found three metabolically distinct
clusters: a glycolytic metabolism state, a starvation
response with induction of metabolism of alternative
carbon sources and an environmental stress response
(Daily et al., 2007). The study by Daily et al. suggests that
parasites can undergo a metabolic shift in vivo, switching
from predominately glycolytic metabolism to metabolism
of alternative carbon sources with induction of gene sets
associated with function of mitochondria and apicoplast.
Despite the complexity of metabolic patterning that
emerges from these types of studies, glucose delivery is
nevertheless essential for parasite survival and may
also be critical for metabolic diversion of this key sub-
strate from host tissues, thereby exacerbating disease
processes. Here, when taken together with previous
studies on PfHT, the central role of PfHT in hexose deliv-
ery to parasites is conﬁrmed.
Fig. 7. Western blot analysis. Ten
micrograms of parasite material from asexual
blood stages, ookinete-enriched culture and
mosquito midguts and salivary glands stages
of PbGFPCON (lane 1) and pbht-gfp line (lane
2) was subjected to SDS-PAGE (10%
acrylamide), transferred to a nitrocellulose
membrane and probed with 1:1000 diluted
anti-GFP antibody (Roche) and 1:3000 diluted
HRP-conjugated anti-mouse antibody.
*Ookinete-enriched culture obtained by
incubation of blood sample of an infected
mouse in the ookinete medium overnight at
19°C. p.i., post infection.
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hexose transporter to a rodent malaria model, P. berghei,
which enabled studies with insect stages of the parasite’s
life cycle. Energy requirements and metabolism during
parasite development in the invertebrate host are largely
unknown, although it is established that gametocytes
display increased expression of TCA cycle and oxidative
phosphorylation enzymes compared with asexual stages
(Hall et al., 2005). In addition to asexual blood stages,
proteome analyses of gametocytes, ookinetes, mosquito
midgut oocysts and sporozoites have been performed.
Proteomic survey of P. berghei life cycle has detected
PbHT expression in asexual blood stages (Hall et al.,
2005) and gametocytes (Khan et al., 2005). Similarly, P.
falciparum proteome studies identiﬁed PfHT expression in
asexual stages and gametocytes (Florens et al., 2002;
Lasonder et al., 2002). More recently, PfHT has been
found expressed in oocyst-derived sporozoites (Lasonder
et al., 2008). These ﬁndings may reﬂect in part method-
ological limitations of applying current proteomic
approaches to the detection of integral membrane
proteins. They suggest that other membrane proteins
should also be examined individually for expression in
different stages of the life cycle. Here we show, by direct
ﬂuorescence as well as Western blot analysis, that PbHT
is expressed in female gametes/or zygotes, ookinetes,
midgut oocysts and sporozoites derived from both midgut
oocysts and salivary glands.
Furthermore, the importance of glucose transport for a
cell may be inferred from the presence of expressed gly-
colytic enzymes. In the P. falciparum sporozoite pro-
teome, with an exception of 6-phosphofructokinase, all
glycolytic enzymes have been detected. However, this
enzyme has been detected in the P. berghei sporozoite
proteome, indicating that its absence from P. falciparum
sporozoite proteome is probably due to the limitations of
detection technology rather than true absence. Therefore,
available proteomic data and our data presented here
together suggest that the sugar uptake and glycolysis are
present in sporozoites. Joet et al. (2002) analysed tem-
perature dependence of Plasmodium hexose transporters
activity and showed that they are active in a broad tem-
perature range, with approximately 50 % of maximal activ-
ity retained at 20°C. This ﬁnding shows that these
transporters can function in insect stages of development
that take place at 22–26°C.
Further studies will evaluate potential of speciﬁc PfHT
inhibitors in reducing gametocytaemia in culture. Novel
drugs that would have activity against both asexual blood
stages and gametocytes are necessary if the malaria
research community is aiming towards the eradication of
the disease.
These studies may help in identifying inhibitors of PfHT
that can contribute to the challenging drug discovery
process. Indeed, glucose is an essential energy sub-
strate, not only for malaria parasites, but for other unre-
lated parasites as well, such as the kinetoplastida (Barrett
et al., 1998; Burchmore et al., 2003).
Experimental procedures
Ethics statement
All animal work has passed an ethical review process and
was approved by the United Kingdom Home Office. Work
was carried out in accordance with the United Kingdom
‘Animals (Scientiﬁc Procedures) Act 1986’ and in compliance
with ‘European Directive 86/609/EEC’ for the protection of
animals used for experimental purposes.
Construction of plasmids for transfection of P. falciparum
pCAM-BSD-HT. A 1.2 kb fragment of the central region of
pfht [nucleotides 163–1348 of the pfht open reading frame
(ORF)] was ampliﬁed using primers KOHTf and KOHTr
(Table 1). An ampliﬁed fragment was inserted into the pCAM-
Table 1. P. falciparum primer sequences.
Primer Sequence
Knockout fragment KOHTf 5′-CAGGATCCGTTGTAGAATTTGAATGGTGTAAAGG
KOHTr 5′-caGCGGCCGCTAATAATGTCTGATGGGAAGACAAC
Complementation gene XKBNf 5′-CCAAGTCGGTTGTATGAGCGGCCGCTTACCACTAAACCAGCC
XKBNr 5′-GGCTGGTTTAGTGGTAAGCGGCCGCTCATACAACCGACTTGG
PCR detection of knockout
plasmid integration
15 ′-TATATATAAAATGAGGAATTGGAAAATTTTTC
25 ′-AATGGAATAAATGTCGATTGGATAATGTTTG
35 ′-TATTCCTAATCATGTAAATCTTAAA
45 ′-CAATTAACCCTCACTAAAG
Real-time PCR analysis PfHT-f 5′-GAAATGTTTCCATCAGAAATAAAAG
PfHT-r 5′-GAATCGAAGGGGATTTCTTAATA
PfHT probe 5′-CAACAATAATTGCACAAACCCAATTAACTAATGA
Tubulin-f 5′-TGATGTGCGCAAGTGATCC
Tubulin-r 5′-TCCTTTGTGGACATTCCTTCCTC
Tubulin probe 5′-TAGCACATGCCGTTAAATATCTTCCATGTCT
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et al., 2005). The resulting plasmid, pCAM-BSD-HT was used
in transfections as a gene disruption (knockout) vector.
pCHD-HT. Xkb.1 plasmid contains the full-length pfht gene
ﬂanked by BglII sites and was used as a source of the pfht
gene (Woodrow et al., 1999). First, a pair of complementary
PCR primers (XKBNf and XKBNr, Table 1) was used in site-
directed mutagenesis to convert a 3′ BglII site immediately
after the stop codon into a NotI site generating the XkbN
plasmid. Subsequently, the pfht gene was subcloned from
XkbN plasmid into a pHGB vector downstream of the pfhsp86
promoter using BglII and NotI restriction sites (Tonkin et al.,
2004). The resulting plasmid, pHGB-HT, was used as an
entry vector in a LR recombination reaction with the destina-
tion vector, pCHD that contains DHFR cassette conferring
resistance to WR99210 (Tonkin et al., 2004).After the recom-
bination reaction, the resulting vector, pCHD-HT, contains
pfht gene under the control of pfhsp86 promoter and the
DHFR resistance cassette, and was used in co-transfections
as a complementation plasmid.
All transfection constructs were veriﬁed by sequence
analysis.
P. falciparum culture and transfection
Plasmodium falciparum 3D7 clone was grown as described
previously (Trager and Jensen, 1976) and used for
transfections. Parasites were sorbitol-synchronized, and ring-
stage parasites were subjected to electroporation in the pres-
ence of 100 mg of pCAM-BSD-HT plasmid or 50 mg of both
pCAM-BSD-HT and pCHD-HT plasmids, as described previ-
ously (Dorin-semblat et al., 2007). Blasticidin (2.5 mgm l
-1)
and WR99210 (5 nM) were added 48 h after transfection to
select for transformed parasites. Blasticidin-resistant para-
sites appeared in culture 14 days post transfection and para-
sites resistant to both blasticidin and WR99210 appeared 19
days after transfection.
After the detection of homologous integration of the knock-
out vector in doubly transfected parasites by PCR, they were
subjected to blasticidin cycling to select for parasites with
pCAM-BSD-HT integrated into the genome. The cycling con-
sisted of 3 weeks of culturing without blasticidin, followed by
3 weeks with blasticidin pressure. This selection cycle was
repeated twice. No decrease in parasiteamia was observed
after reapplying the drug pressure.
Genotype characterization
Plasmid rescue of episomes. Parasite pellets were obtained
by saponin lysis and genomic DNA was extracted by protein-
ase K (0.1 mg ml
-1) and SDS (2%) treatment for 2 h at 55°C.
Genomic DNA extracted from both knockout and
co-tranfected parasites was used to transform E. coli super-
competent cells. Plasmid DNA was isolated from obtained
bacterial clones using standard methods and digested with
BamHI and NotIo rBglII and NotI.
PCR. PCR analysis of transfectants was performed on
genomic DNA using Taq polymerase (Sigma) and following
cycling conditions: 1 cycle at 92°C (2 min); 35 cycles at 92°C
(30 s), 54°C (45 s) and 65°C (1.5 min) and 1 cycle at 65°C
(5 min). Sequences of primers used are shown in Table 1.
PCR primers 1 and 2 anneal to the pfht wild-type locus
outside the ORF region inserted in pCHD-HT. Primers 3 and
4 anneal to the pCAM-BSD-HT and ﬂank the insertion site.
Four different combinations of primers were used in order
to detect: the wild-type pfht locus (primers 1 and 2), 5′ end of
integration event (primers 1 and 4), 3′ end of the integration
event (primers 2 and 3) and the presence of episome
(primers 3 and 4).
Southern blotting. Genomic DNA extracted from parasite
pellet obtained by saponin lysis was digested with SwaI, NcoI
and EcoNI. pCAM-BSD-HT and pCHD-HT plasmid DNAwere
also digested with same enzymes and used as controls. One
microgram of digested genomic DNA and 1.5 ng of digested
plasmid DNAwere separated on 0.8% agarose gel and trans-
ferred to positively charged nylon membrane (Hybond-XL,
Amersham). Subsequently, the membrane was hybridized
overnight at 58°C with 1 kb pfht knockout fragment labelled
with
32P-dCTP (Sambrook et al., 1989).
Phenotype characterization
Quantitative PCR. Parasites were sorbitol-synchronized and
frozen down in RNA-Later solution (Ambion) for RNA extrac-
tion at rings (~10 h post invasion) and trophozoite stages
(~30 h post invasion). RNAwas isolated with RNAisolation kit
(Qiagen) according to manufacturer’s instructions. Isolated
RNA was treated with DNase I (Promega) and used in
reverse transcription reactions (High Capacity cDNAReverse
Transcription Kit with RNase inhibitor, Applied Biosystems).
Quantiﬁcation of the gene expression was assessed by
TaqMan real-time PCR (Stratagene Mx3005P QPCR
System). Primers and probes are summarized in Table 1. The
pfht probe was FAM-labelled at the 5′ end, and the b-tubulin
probe was VIC-labelled. Both probes had a TAMRAquencher
at the 3′ end. Ampliﬁcation reactions were done as duplex
PCR in 96-well plates using TaqMan Universal PCR Master
Mix (Applied Biosystems). pfht primers and probe concentra-
tions were 600 nM and 40 nM respectively. b-tubulin primers
and probe were all used at 100 nM (Price et al., 2004). The
following cycling conditions were applied: 95°C 10 min, fol-
lowed by 45 cycles of 95°C (15 s) and 57°C (1 min). Reac-
tions were done in triplicate and experiments repeated three
times.
Relative pfht expression in complemented parasites com-
pared with calibrator (3D7 parasites) was calculated using
the efficiency-corrected comparative quantiﬁcation method.
b-tubulin was used as a normalizer gene. A standard curve
was run together with experimental samples during each run
to estimate the efficiencies of target (pfht) and normalizer
(b-tubulin) assays. The following equation was used to cal-
culate relative quantity to the calibrator: (1 + EGOI)
DCtGOI/
(1 + Enorm)
DCtnorm, where EGOI and Enorm are efficiencies of the
target and the normalizer assays and DCt = (Ctcalibrator –
Ctunknown). Primers sequences are in Table 1.
Parasite growth and sensitivity to CM3361. 3-O-(undec-10-
en)-yl-D-glucose (CM3361) was synthesized as described
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inhibitor CM3361 on the growth inhibition of the wild-type
and complemented parasites was determined using the
[
3H]-hypoxanthine incorporation assay as previously
described. Ring-stage parasites were seeded in the 96-well
plates at 0.5% parasitemia and 2% hematocrit in the pres-
ence of increasing concentrations of the inhibitor (ﬁve repli-
cates per inhibitor concentration). [
3H]-hypoxanthine was
added after 24 h of incubation and parasites harvested after
48 h. Five independent experiments were performed.
Statistical analysis. For P. falciparum IC50 assays, a sigmoi-
dal dose–response model with the variable slope was ﬁtted to
results using GraphPad Prism (Version 4 for Macintosh). IC50
values obtained with the wild-type and the complemented
parasite line were compared using Student’s t-test (unpaired,
two-tailed). For the analysis of pfht mRNA expression, the
relative pfht expression in the complemented parasite line
was compared with 3D7 parasites using one sample t-test.
Statistical signiﬁcance was set at P  0.05.
P. berghei culture and transfection
Transfection experiments were performed on P. berghei
ANKA strain 2.34 parasites according to a described protocol
(Janse et al., 2006). The pbht knockout vectors were con-
structed for a double cross-over homologous recombination
in the pBS-DHFR plasmid that contains a Toxoplasma gondii
dhfr/ts cassette conferring resistance to pyrimethamine
(Dessens et al., 1999). The knockout construct was gener-
ated by inserting 0.8 kb of the pbht 5′ untranslated (UTR)
region upstream and 1 kb of the pbht 3′ UTR region down-
stream of the dhfr cassette (sequences of primers used to
amplify fragments from P. berghei genomic DNA are given in
Table 2). The ﬁnal knockout construct was digested with KpnI
and NotI to release the fragment for transfection.
To generate a pbht-gfp construct for a single cross-over
homologous recombination, a 1 kb region of the pbht without
the stop codon was inserted in frame and upstream of the gfp
sequence in the plasmid p277 containing the human dhfr
cassette and conveying resistance to pyrimethamine (Liu
et al., 2008). Prior to transfection, the ﬁnal construct was
digested with BstXI that cuts the plasmid in the middle of the
insert, which is optimal for the homologous recombination
event.
Transfected P. berghei parasites were selected with
pyrimethamine selection pressure according to a described
protocol (Janse et al., 2006). Transfection of P. berghei para-
sites with the knockout construct was carried out minimum of
three times.
Genotype analysis of P. berghei transfectants
PCR. PCR analysis was used to inspect if the transfec-
tion construct was integrated into the correct locus in
pyrimethamine-resistant parasites. For the analysis of para-
sites transfected with the pbht knockout construct, combina-
tions of the following four primers were used to explore the
pbht locus: primer 539 anneals to the DHFR cassette in the
construct, primers Pb7 and Pb8 anneal to the pbht 3′ UTR
inserted in the construct, whereas primer Pb9 anneals further
downstream from Pb8 in pbht 3′ UTR and does not anneal to
the sequences present in the construct. For the analysis of
pbht-GFP transgenic parasites, Pb1, Pb8, Pb11 and gfpr
primers were used.
Southern blot. Genomic DNAextracted from pbht-GFP para-
site pellet obtained by lysis with NH4Cl was digested with
BsrGI. One microgram of digested genomic DNA was sepa-
rated on 0.8% agarose gel and transferred to a positively
charged nylon membrane (Hybond-XL, Amersham) that was
hybridized overnight at 55°C with 1 kb pbht probe labelled
with
32P-dCTP.
Analysis of the HT- GFP localization during malaria
life cycle
Images of GFP-expressing parasites were captured with
LSM 510 METAConfocal Laser Scanning Microscope (Zeiss)
and Leica SP5 confocal microscope. Hoechst33342 or DAPI
were used for nuclear staining of blood stages parasites and
ookinetes. Anopheles stephensi mosquitoes were fed on
mice infected with P. berghei pbht-gfp and PbGFPCON para-
Table 2. P. berghei primers sequences.
Primer Sequence
PbHT 5′ UTR Pb1 5′-cgaGGTACCGTGTAAAAATTTATCGTTAAGAGAG
Pb2 5′-CATGGGCCCTTTTTTCGTATTAATACACATATATTTCTTG
PfHT ORF Pb3 5′-AAAGGGCCCATGACGAAAAGTTCGAAAGAT
Pb4 5′-caaGTCGACTCATACAACCGACTTGGTCATATG
Spacer 3′ UTR Pb5 5′-atcGTCGACATTTTGATACGCATAAATCGTATAG
Pb6 5′-catAAGCTTTTTGATACATATATATTTGATACATATATATTTG
PbHT 3′ UTR Pb7 5′-gtcGATATCATTTTGATACGCATAAATCGTATAGATATAG
Pb8 5′-caaGCGGCCGCAAAAAAATAGAAATCAAATGATATATATTTACCC
PbHT-GFP fragment Pb10 5′-catGGTACCTAACATTTGGAATATTTGTTGCAGTTTTATTGGG
Pb11 5′-caaGGGCCCAACTCTTGATTTGCTTATATGTTTTTGTCTTTCTTC
Integration detection Pb9 5′-CACCATTTTATTCACCATATTTTTAC
539 5′-CAATGATTCATAAATAGTTGGACTTG
gfpr 5′-ACGCTGAACTTGTGGCCG
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infection, mosquitoes were dissected and midguts were col-
lected for direct ﬂuorescence imaging and Western blotting
analysis (~30 midguts per parasite strain). Dissection of mos-
quitoes was repeated at day 21 post infection when midguts
and salivary glands were collected for the analysis of pbht
expression.
Western blot analysis. For Western blot analysis parasite
pellets of pbht-GFP and PbGFPCON (Franke-Fayard et al.,
2004). P. berghei blood stages were obtained by erythrocytes
lysis with NH4Cl. Pellets of mosquitoes’ midguts and salivary
glands were ground with pestle and pellets resuspended in
PBS containing Complete™ protease inhibitor cocktail
tablets (Roche). Approximately 10 mg of each extract were
heated at 70°C in NuPAGE
® LDS Sample Buffer (Invitrogen),
separated on Novex
® 10% Bis-Tris gel (Invitrogen)
and electro-transferred to a nitrocellulose membrane
(Amersham). Membranes were blocked overnight at 4°C in
PBS containing 5% skimmed milk and 0.1% Tween 20. Blots
were probed with a mouse monoclonal GFP antibody
(Roche), diluted 1:1000. Bound antibodies were detected
with a HRP-conjugated anti-mouse secondary antibody,
diluted 1:3000 (Bio-Rad) and ECL Western Blotting detection
reagents (Amersham).
Ookinete culture. Blood was taken from a pbht-gfp infected
mouse on day 4 post infection into a heparinized syringe,
mixed with the ookinete culture medium (RPMI1640 contain-
ing 25 mM HEPES, 25% fetal bovine serum, 10 mM sodium
bicarbonate, 50 mM xanthurenic acid, pH 7.6) and cultured at
19°C for a further 21–24 h. For direct immunolabelling cul-
tured cells were pelleted for 2 min at 800 g and then labelled
for 10 min on ice in 50 ml of ookinete medium containing
Hoechst33342 and Cy3-conjugated mouse monoclonal anti-
body speciﬁc for P28 (Reininger et al., 2009).
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